![]() |
市场调查报告书
商品编码
1828107
2025年电脑刀全球市场报告Cyberknife Global Market Report 2025 |
近年来,电脑刀市场规模迅速扩张,从2024年的6.3亿美元成长到2025年的7.2亿美元,复合年增长率达15.8%。预测期内的增长归因于癌症发病率上升、人口老化、精准医疗需求、患者对非侵入性手术的偏好以及放射治疗的进步。
预计未来几年,电脑刀市场规模将快速成长,到2029年将达到13.4亿美元,复合年增长率为16.5%。预测期内的成长归因于全球癌症负担的增加、肿瘤学研究的进步、医疗保健可及性的提高、认知和教育的增强以及与多学科方法的整合。预测期内的主要趋势包括质子治疗整合度的提高、向门诊和独立中心的转变、以患者为中心的治疗计划、临床证据和研究的增加以及远端医疗和远端医疗计划。
电脑刀系统为恶性肿瘤、非恶性肿瘤以及其他需要放射治疗的疾病提供非侵入性治疗方案。该系统旨在缩小肿瘤周围的治疗范围,最大限度地减少健康组织暴露于高剂量放射线。
电脑刀系统提供基于直线加速器和独立配置两种版本。基于线性加速器的 电脑刀系统将线性加速器基座直接整合到机器人平台上,以发射放射治疗所需的高能量光子或 X 射线。 Cyber 电脑刀加速器用于精确发射放射治疗所需的高能量 X 射线或光子。 Cyber 电脑刀系统广泛应用于医疗保健机构,包括医院、诊所、门诊手术中心和放射治疗机构。它提供了一种先进的非侵入式放射治疗方法,使其成为治疗肿瘤、癌症、血管畸形和其他多种疾病的重要工具。
2025年春季,美国关税飙升及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要重新认证医疗设备,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司最新报告系列的一部分,该系列提供电脑刀市场统计数据,例如全球电脑刀行业市场规模、各地区市场份额、竞争对手的市场份额、电脑刀电脑刀细分市场、市场趋势和商业机会,提供在电脑刀行业取得成功所需的所有数据。本电脑刀市场研究报告提供了全面的展望,并详细分析了该行业的现状和未来趋势。
未来五年16.5%的预测成长率,较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这可能会直接影响美国,对来自加拿大和丹麦等关键地区的机械手臂和即时肿瘤追踪软体征收关税,从而导致放射治疗延误和精准癌症治疗成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,其影响将更加广泛。
癌症是一种严重的疾病,其特征是细胞快速且不受控制地繁殖,导致异常增殖,因此,随着癌症发生率的不断上升,预计电脑刀市场将会成长。 Cyber 电脑刀被核准用于治疗各种癌症,在建议进行放射治疗时,它提供了一种非侵入性、无痛的替代疗法。正在进行的研究和开发旨在增强电脑刀系统并扩展其应用以应对新出现的医疗状况,预计将促进市场成长。例如,正如 ABC News Internet Ventures 在 2022 年 1 月报导的那样,预计 2022 年将诊断出约 200 万例新癌症病例,比 2021 年报告的数百万新患者有显着增长。癌症发生率的上升(美国每天诊断出约 5,250 例新病例)正在推动电脑刀市场的成长。
人们对非侵入性或微创手术日益增长的偏好进一步推动了电脑刀市场的成长。微创手术是一种将对正常身体结构损伤降至最低的医疗程序。作为一种机器人放射线手术系统,电脑刀比微创手术具有多项优势,包括精准的肿瘤靶向、对移动目标的适应性、减少治疗次数以及提高患者舒适度。根据美国整形外科医师协会 (ASPS) 2023 年 9 月的数据,2022 年共实施了约 2,370 万例美容微创手术。尤其是涉及调变器注射的微创手术数量较 2019 年激增 73%,到 2022 年达到约 8,736,591 例。微创手术的显着成长凸显了人们对此类方法日益增长的偏好,以及它们对电脑刀市场成长的贡献。
电脑刀市场的新兴市场正专注于开发创新解决方案,例如医疗培训计划,以提高治疗准确性、患者治疗效果并扩大可治疗的疾病范围,同时减少与传统放射线治疗相关的副作用。医疗培训计划是结构化的教育计划,旨在提高医疗专业人员的技能和知识,并专注于最佳实践,以改善特定的医疗技术、治疗和患者照护。例如,美国放射治疗系统製造商 Accuray Incorporated 于 2024 年 9 月开始在其教育中心对医疗专业人员进行电脑刀 S7 系统的培训。该设施是一个综合培训中心,旨在使参与放射线手术和放射治疗的医疗专业人员能够获得电脑刀和 Radixact 系统的实践经验,并接受根据他们个人需求量身定制的培训计划。
电脑刀市场的主要企业正专注于开发线上自适应治疗解决方案。线上自适应治疗涉及放射治疗中动态、即时的治疗计划和实施方法。例如,Accuray Incorporated 于 2023 年 10 月推出了“Cenos”,这是一款专为 Radixact 系统设计的线上自适应治疗方案。 Cenos 让患者在治疗台上根据需要快速有效地修改治疗计划。这种整合使 Accuray 客户能够在线上调整治疗计划,以适应治疗期间可能出现的变化。
2022年9月,总部位于美国的放射治疗品质保证解决方案供应商Standard Imaging收购了Integrated Medical Technologies (IMT),以增强其产品组合和市场覆盖范围。此次收购旨在透过整合互补解决方案、提升生产能力以及拓展其市场区隔(尤其是在组织等效剂量体模领域)来更好地服务IMT的客户群。总部位于美国的Integrated Medical Technologies (IMT)专注于放射治疗和医学成像体模,用于放射治疗和诊断,这与Standard Imaging在放射治疗领域提供全面解决方案的目标一致。
电脑刀市场的主要企业包括 Accuray Incorporated、Elekta AB、Medtronic plc、Varian Medical Systems Inc、Brainlab AG、Ion Beam Applications SA、Mevion Medical Systems Inc、Zap Surgical Systems Inc、Xcision Medical Systems LLC. Corporation、Orfit Industries NV、Technicare Medical Systems Inc.、ProTom International Inc.、Advanced Accelerator Applications SA、Theragenics Corporation、IntraOp Medical Corporation、CIVCO RadIoTherapy、IsoRay Medical Inc.、RaySearch Laboratories AB、RefleXion Medical Inc.、Shin Software Inc.Shin Software Inc.
2024 年,北美是电脑刀市场最大的地区。 电脑刀市场报告涵盖以下地区:亚太地区、西欧、东欧、北美、南美以及中东和非洲。
电脑刀的国家:澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙
电脑刀市场涵盖机器人直线加速器、机器人操纵器、影像引导系统和影像追踪系统的销售。该市场的价值指的是“出厂价”,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。
The CyberKnife System offers a non-invasive treatment solution for both malignant and non-cancerous tumors, as well as other medical conditions necessitating radiation therapy. This innovative system is designed to enable smaller treatment margins around tumors, thereby minimizing exposure to high radiation doses for healthy tissues.
The primary categorizations of the CyberKnife system include linear accelerator-based and standalone CyberKnife models. Linear accelerator-based CyberKnife refers to a system incorporating a linear accelerator (linac) directly onto a robotic platform for the delivery of high-energy photons or X-rays essential for radiation therapy. This specific type of CyberKnife device utilizing a linear accelerator is employed to administer precise and high-energy X-rays or photons for radiation therapy applications. CyberKnife systems find extensive use in healthcare settings such as hospitals, clinics, ambulatory surgical centers, and radiotherapy facilities. They serve as integral tools for treating tumors, cancer, vascular malformations, and various other medical conditions, providing a sophisticated and non-invasive approach to radiation therapy.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The cyberknife market research report is one of a series of new reports from The Business Research Company that provides cyberknife market statistics, including cyberknife industry global market size, regional shares, competitors with a cyberknife market share, detailed cyberknife market segments, market trends, and opportunities, and any further data you may need to thrive in the cyberknife industry. This cyberknife market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cyberknife market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.72 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to rising cancer incidence, growing aging population, demand for precision medicine, patient preference for non-invasive procedures, advancements in radiotherapy.
The cyberknife market size is expected to see rapid growth in the next few years. It will grow to $1.34 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to increasing cancer burden worldwide, advancements in oncology research, expanding access to healthcare, rising awareness and education, integration with multidisciplinary approaches. Major trends in the forecast period include rise in proton therapy integration, shift towards outpatient and freestanding centers, patient-centric treatment planning, growing clinical evidence and research, telemedicine and remote treatment planning.
The forecast of 16.5% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on robotic manipulator arms and real-time tumor tracking software, sourced from key regions such as Canada and Denmark, which could lead to delayed radiation therapy treatments and increased costs for precision cancer care.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated growth in the cyberknife market is driven by the increasing incidence of cancer, a severe disorder characterized by rapid and uncontrolled cell reproduction leading to abnormal growth. CyberKnife, approved for the treatment of various cancers, presents a non-invasive and pain-free alternative in cases where radiation therapy is recommended. Ongoing research and development efforts aimed at enhancing the CyberKnife system and expanding its applications to address additional medical conditions are expected to contribute to the market's growth. For instance, as reported by ABC News Internet Ventures in January 2022, the projected number of newly diagnosed cancer cases in 2022 is around 2 million, representing a significant increase compared to the 1 million new cases reported in 2021. The escalating incidence of cancer, with approximately 5,250 new cases diagnosed daily in the United States, underscores the driving force behind the growth of the cyberknife market.
The growth of the cyberknife market is further propelled by the increasing preference for non-invasive or minimally invasive procedures. Minimally invasive interventions involve medical procedures that cause minimal disruption to the body's normal structures. CyberKnife, as a robotic radiosurgery system, offers several advantages in minimally invasive procedures, including precise tumor targeting, adaptability to moving targets, a reduced number of treatment sessions, enhanced patient comfort, and more. According to The American Society of Plastic Surgeons (ASPS) data in September 2023, approximately 23.7 million cosmetic minimally invasive procedures were performed in 2022. Specifically, the number of minimally invasive procedures involving Neuromodulator Injections surged by 73% from 2019, reaching approximately 8,736,591 procedures in 2022. This substantial growth in minimally invasive procedures highlights the increasing preference for such approaches and their contribution to the growth of the cyberknife market.
Key players in the CyberKnife market are concentrating on developing innovative solutions, including medical training programs, to enhance treatment precision, improve patient outcomes, and broaden the range of conditions that can be treated while reducing side effects associated with traditional radiation therapies. Medical training programs are structured educational initiatives designed to improve the skills and knowledge of healthcare professionals, focusing on specific medical technologies, treatments, and best practices to enhance patient care. For instance, in September 2024, Accuray Incorporated, a U.S.-based manufacturer of radiation therapy systems, launched medical professional training for the CyberKnife S7 System at its education center. This facility serves as a comprehensive training hub aimed at equipping medical professionals involved in radiosurgery and radiotherapy with tailored training programs and hands-on experience with the CyberKnife and Radixact systems.
Major players in the cyberknife market are directing their efforts towards the development of online adaptive therapy solutions. Online adaptive therapy involves a dynamic and real-time approach to treatment planning and delivery in radiation therapy. For instance, in October 2023, Accuray Incorporated introduced 'Cenos,' an online adaptive therapy option specifically designed for the Radixact System. Cenos empowers medical care teams to swiftly and effectively modify a treatment plan if necessary while the patient is still on the treatment table. Its integration enables Accuray customers to conduct online adaptation of treatment plans, accommodating changes that may arise between treatment sessions.
In September 2022, Standard Imaging, a US-based provider of quality assurance solutions in radiation therapy, acquired Integrated Medical Technologies (IMT) to enhance its offerings and market reach. This acquisition aims to better serve IMT's customer base by integrating complementary solutions, expanding production capabilities, and broadening market segments, particularly in tissue-equivalent dosimetry phantoms. Integrated Medical Technologies (IMT), a US-based company specializing in radiation therapy and medical imaging phantoms for both radiotherapy and diagnostic applications, aligns with Standard Imaging's objectives to provide comprehensive solutions in the radiation therapy domain.
Major companies operating in the cyberknife market include Accuray Incorporated, Elekta AB, Medtronic plc, Varian Medical Systems Inc., Brainlab AG, Ion Beam Applications S.A., Mevion Medical Systems Inc., Zap Surgical Systems Inc., Xcision Medical Systems LLC, ViewRay Inc., Hitachi Ltd., Mitsubishi Electric Corporation, Best Theratronics Ltd., Siemens Healthineers AG, Toshiba Medical Systems Corporation, Orfit Industries NV, Technicare Medical Systems Inc., ProTom International Inc., Advanced Accelerator Applications S.A., Theragenics Corporation, IntraOp Medical Corporation, CIVCO Radiotherapy, IsoRay Medical Inc., RaySearch Laboratories AB, RefleXion Medical Inc., Shinva Medical Instrument Co. Ltd., Klarity Medical Products, MIM Software Inc., Elekta Instrument AB, Nordion Inc.
North America was the largest region in the cyberknife market in 2024. The regions covered in the cyberknife market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the cyberknife market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cyberknife market consists of sales of robotic linac, robotic manipulator, image guidance system, image tracking system. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cyberknife Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cyberknife market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cyberknife ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cyberknife market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.